AAPL 165.4 -1.34 (-0.80%)MSFT 106.08 -1.4 (-1.30%)FB 144.04 -1.32 (-0.91%)ZNGA 3.71 +0.04 (+1.23%)NVDA 146.45 -1.46 (-0.99%)WBA 78.69 -0.4 (-0.51%)GOOG 1041.79 -8.01 (-0.76%)PIH 5 -0.12 (-2.34%)
AAPL 165.4 -1.34 (-0.80%)MSFT 106.08 -1.4 (-1.30%)FB 144.04 -1.32 (-0.91%)ZNGA 3.71 +0.04 (+1.23%)NVDA 146.45 -1.46 (-0.99%)WBA 78.69 -0.4 (-0.51%)GOOG 1041.79 -8.01 (-0.76%)PIH 5 -0.12 (-2.34%)

Cash Flow ABBV Quote AbbVie Inc.

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
NetIncome 5,144 5,953 5,309
Depreciation 836 1,189 1,501
DeferredIncomeT 0 0 1,242
StockBasedCompe 282 353 365
AccountsReceiva 0 -71 -391
InventoryCS -434 -38 93
AccountsPayable 1,503 -1,187 425
OtherWorkingCap -1,076 0 0
OtherNonCashIte 769 1,235 1,180
NetCashProvided 7,535 7,041 9,960
InvestmentsInPP -532 -479 -529
AcquisitionsNet -11,488 -2,495 0
PurchasesOfInve -1,815 -5,577 -2,538
SalesMaturities 880 2,359 2,793
PurchasesOfInta 0 0 0
OtherInvestingA 19 118 0
NetCashUsedForI -12,936 -6,074 -274
DebtIssued 20,660 11,627 0
DebtRepayment -4,018 -6,010 -25
CommonStockIssu 0 0 0
CommonStockRepu -7,567 -6,033 -1,410
DividendPaid -3,294 -3,717 -4,107
OtherFinancingA -29 205 30
NetCashProvided 5,752 -3,928 -5,512
NetChangeInCash 51 -3,299 4,203
CashAtBeginning 8,348 8,399 5,100
CashAtEndOfPeri 8,399 5,100 9,303
AbbVie Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes AbbVie Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.